Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Charleston, South Carolina 29425


Transition from tacrolimus based triple therapy with Mycophenolate Mofetil (MMF) and steroids in stable renal transplant patients to low intensity tacrolimus, everolimus and prednisone will be associated with improvement in Glomular Filtration Rate (GFR) and allograft fibrosis.


Inclusion Criteria: 1. At least 18 years of age and able to give informed consent. 2. Received a first or repeat cadaveric (including ECD) or living donor renal transplant. 3. Patient has stable graft function, defined as no change of greater than 40% of baseline serum creatinine and no acute rejection during the past month. 4. Currently receiving tacrolimus, mycophenolate mofetil and prednisone as their immunosuppression regimen Exclusion Criteria: 1. Biopsy proven acute rejection episode that occurred within the past month. 2. Malignancy within the past 3 years, except for non-melanoma skin cancer. 3. Currently enrolled in an investigational drug trial. 4. Woman of child bearing potential not utilizing an effective form of birth control. 5. Patients with uncontrolled dyslipidemia, defined at serum fasting LDL >200 mg/dL or serum fasting triglycerides >500 mg/dL. 6. Patients with a spot urine protein to creatinine ratio of > 800 mg of protein per gram of creatinine. 7. WBC < 2,000 cells/mm3 8. Platelets < 75,000 cells/mm3 9. Patients who have received an organ transplant other than a kidney. 10. Patients with a history of biopsy proven FSGS, MPGN, or PGN.



Primary Contact:

Principal Investigator
Titte Srinivas, MD
Medical University of South Carolina

Backup Contact:


Location Contact:

Charleston, South Carolina 29425
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: January 21, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.